GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Planet 13 Holdings Inc (OTCPK:PLNH) » Definitions » Buyback Yield %

PLNH (Planet 13 Holdings) Buyback Yield % : -7.99 (As of Dec. 16, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Planet 13 Holdings Buyback Yield %?

Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.

Planet 13 Holdings's current buyback yield was -7.99%.


Planet 13 Holdings Buyback Yield % Historical Data

The historical data trend for Planet 13 Holdings's Buyback Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Planet 13 Holdings Buyback Yield % Chart

Planet 13 Holdings Annual Data
Trend Jun16 Jun17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Buyback Yield %
Get a 7-Day Free Trial -1.86 -4.73 -9.16 - -

Planet 13 Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Buyback Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - -26.94 0.14 -

Competitive Comparison of Planet 13 Holdings's Buyback Yield %

For the Drug Manufacturers - Specialty & Generic subindustry, Planet 13 Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Planet 13 Holdings's Buyback Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Planet 13 Holdings's Buyback Yield % distribution charts can be found below:

* The bar in red indicates where Planet 13 Holdings's Buyback Yield % falls into.



Planet 13 Holdings Buyback Yield % Calculation

Buyback yield is a measure of shareholder return.

Planet 13 Holdings's Buyback Yield for the fiscal year that ended in Dec. 2023 is calculated as

Buyback Yield=Net Issuance of Stock / Market Cap
=- (Repurchase of Stock + Issuance of Stock) / Market Cap
=- (0 + 0) / 142.9452117
=0.00%

Planet 13 Holdings's annualized Buyback Yield for the quarter that ended in Sep. 2024 is calculated as

Buyback Yield=Net Issuance of Stock(Annualized) / Market Cap
=- (Repurchase of Stock + Issuance of Stock) * Annualized Factor / Market Cap
=- (0 + 0) * 4 / 195.0984
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In calculating the annualized quarterly data, the Repurchase of Stock and Issuance of Stock data used here is four times the quarterly (Sep. 2024) data.


Planet 13 Holdings Buyback Yield % Related Terms

Thank you for viewing the detailed overview of Planet 13 Holdings's Buyback Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


Planet 13 Holdings Business Description

Traded in Other Exchanges
Address
2548 West Desert Inn Road, Suite 100, Las Vegas, NV, USA, 89109
Planet 13 Holdings Inc operates as an integrated cannabis company based in Nevada, with cultivation, production, and dispensary operations in Las Vegas. The company is focused on providing an unparalleled dispensary experience and optimizing cultivation efficiencies through its technology as the vanguard of cannabis.
Executives
Chris Wren officer: VP of Operations 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Dennis Logan officer: CFO 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Leighton Koehler officer: General Counsel 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Larry Scheffler director, 10 percent owner, officer: Co-CEO 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
David Farris officer: VP of Sales & Marketing 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Adrienne O'neal director 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
William Vargas officer: VP of Finance 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Robert Groesbeck director, 10 percent owner, officer: Co-CEO 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Lee Fraser director 4675 W TECO AVE, SUITE 250, LAS VEGAS NV 89118
Todd Hybels officer: VP of Midwestern Operations 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Michael Lanteri Jennings officer: Pres. of East Coast Operations 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109
Michael Harman director 2548 WEST DESERT INN ROAD, SUITE 100, LAS VEGAS NV 89109